Literature DB >> 29571586

Personalized Transcranial Magnetic Stimulation in Psychiatry.

Luca Cocchi1, Andrew Zalesky2.   

Abstract

Transcranial magnetic stimulation (TMS) is a noninvasive brain stimulation technique that allows for modulating the activity of local neural populations and related neural networks. TMS is touted as a viable intervention to normalize brain activity and alleviate some psychiatric symptoms. However, TMS interventions are known to be only moderately reliable, and the efficacy of such therapies remains to be proven for psychiatric disorders other than depression. We review new opportunities to personalize TMS interventions using neuroimaging and computational modeling, aiming to optimize treatment to suit particular individuals and clinical subgroups. Specifically, we consider the prospect of improving the efficacy of existing TMS interventions by parsing broad diagnostic categories into biologically and clinically homogeneous biotypes. Biotypes can provide distinct treatment targets for optimized TMS interventions. We further discuss the utility of computational models in refining TMS personalization and efficiently establishing optimal cortical targets for distinct biotypes. Personalizing cortical stimulation targets, treatment frequencies, and intensities can improve the therapeutic efficacy of TMS and potentially establish noninvasive brain stimulation as a viable treatment for psychiatric symptoms.
Copyright © 2018 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biotypes; Brain networks; Brain stimulation; Connectivity; Personalized medicine; TMS

Mesh:

Year:  2018        PMID: 29571586     DOI: 10.1016/j.bpsc.2018.01.008

Source DB:  PubMed          Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging        ISSN: 2451-9022


  19 in total

Review 1.  Transcranial magnetic stimulation in obsessive-compulsive disorder: A focus on network mechanisms and state dependence.

Authors:  Luca Cocchi; Andrew Zalesky; Zoie Nott; Geneviève Whybird; Paul B Fitzgerald; Michael Breakspear
Journal:  Neuroimage Clin       Date:  2018-05-23       Impact factor: 4.881

2.  Time to remission analysis for major depressive disorder after repetitive transcranial magnetic stimulation (rTMS).

Authors:  Ann M Manzardo; Brianna Ely; Maria Cristina Davila
Journal:  Ment Illn       Date:  2019-06-11

3.  Repetitive transcranial magnetic stimulation (rTMS) using different TMS instruments for major depressive disorder at a suburban tertiary clinic.

Authors:  Maria Cristina Davila; Brianna Ely; Ann M Manzardo
Journal:  Ment Illn       Date:  2019-03-22

Review 4.  Brain network disintegration as a final common pathway for delirium: a systematic review and qualitative meta-analysis.

Authors:  S J T van Montfort; E van Dellen; C J Stam; A H Ahmad; L J Mentink; C W Kraan; A Zalesky; A J C Slooter
Journal:  Neuroimage Clin       Date:  2019-04-03       Impact factor: 4.881

5.  Functional Imaging to Guide Network-Based TMS Treatments: Toward a Tailored Medicine Approach in Alzheimer's Disease.

Authors:  Chiara Bagattini; Debora Brignani; Sonia Bonnì; Giulia Quattrini; Roberto Gasparotti; Michela Pievani
Journal:  Front Neurosci       Date:  2021-07-05       Impact factor: 4.677

6.  Activity flow underlying abnormalities in brain activations and cognition in schizophrenia.

Authors:  Luke J Hearne; Ravi D Mill; Brian P Keane; Grega Repovš; Alan Anticevic; Michael W Cole
Journal:  Sci Adv       Date:  2021-07-14       Impact factor: 14.136

7.  Pre-supplementary motor network connectivity and clinical outcome of magnetic stimulation in obsessive-compulsive disorder.

Authors:  Gong-Jun Ji; Wen Xie; Tingting Yang; Qianqian Wu; Pengjiao Sui; Tongjian Bai; Lu Chen; Lu Chen; Xingui Chen; Yi Dong; Anzhen Wang; Dandan Li; Jinying Yang; Bensheng Qiu; Fengqiong Yu; Lei Zhang; Yudan Luo; Kai Wang; Chunyan Zhu
Journal:  Hum Brain Mapp       Date:  2021-05-29       Impact factor: 5.038

Review 8.  Repetitive transcranial magnetic stimulation as a potential treatment approach for cannabis use disorder.

Authors:  Tonisha Kearney-Ramos; Margaret Haney
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-03-04       Impact factor: 5.201

9.  Individual deviations from normative models of brain structure in a large cross-sectional schizophrenia cohort.

Authors:  Jinglei Lv; Maria Di Biase; Robin F H Cash; Luca Cocchi; Vanessa L Cropley; Paul Klauser; Ye Tian; Johanna Bayer; Lianne Schmaal; Suheyla Cetin-Karayumak; Yogesh Rathi; Ofer Pasternak; Chad Bousman; Christos Pantelis; Fernando Calamante; Andrew Zalesky
Journal:  Mol Psychiatry       Date:  2020-09-22       Impact factor: 13.437

10.  Precision non-implantable neuromodulation therapies: a perspective for the depressed brain.

Authors:  Lucas Borrione; Helena Bellini; Lais Boralli Razza; Ana G Avila; Chris Baeken; Anna-Katharine Brem; Geraldo Busatto; Andre F Carvalho; Adam Chekroud; Zafiris J Daskalakis; Zhi-De Deng; Jonathan Downar; Wagner Gattaz; Colleen Loo; Paulo A Lotufo; Maria da Graça M Martin; Shawn M McClintock; Jacinta O'Shea; Frank Padberg; Ives C Passos; Giovanni A Salum; Marie-Anne Vanderhasselt; Renerio Fraguas; Isabela Benseñor; Leandro Valiengo; Andre R Brunoni
Journal:  Braz J Psychiatry       Date:  2020-03-16       Impact factor: 2.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.